Unknown

Dataset Information

0

Successful Treatment of Refractory Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis (SAPHO) Syndrome and Paradoxical Psoriasis with Secukinumab: A Case Report.

ABSTRACT: Synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome is a rare chronic inflammatory disease mainly manifested as skin and osteoarticular lesions. Herein, we describe a female patient with SAPHO syndrome exhibited paradoxical psoriasis and primary palmoplantar pustulosis (PPP) worsened during treatment with adalimumab. We then switched to secukinumab and obtained significant improvement in both skin lesions and osteoarticular pain. These findings suggest that secukinumab might be an appropriate option for patients with SAPHO syndrome who present with TNF-α-inhibitor-induced paradoxical psoriasis.

SUBMITTER: Fan D 

PROVIDER: S-EPMC10929232 | biostudies-literature | 2024

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Successful Treatment of Refractory Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis (SAPHO) Syndrome and Paradoxical Psoriasis with Secukinumab: A Case Report.

Fan Danyang D   Li Fuqiu F   Liu Zhe Z   Tang Zhanhan Z   Lv Sha S  

Clinical, cosmetic and investigational dermatology 20240305

Synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome is a rare chronic inflammatory disease mainly manifested as skin and osteoarticular lesions. Herein, we describe a female patient with SAPHO syndrome exhibited paradoxical psoriasis and primary palmoplantar pustulosis (PPP) worsened during treatment with adalimumab. We then switched to secukinumab and obtained significant improvement in both skin lesions and osteoarticular pain. These findings suggest that secukinumab might  ...[more]

Similar Datasets

Unknown Synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome presenting with a cervical vertebral fracture: A case report
| S-EPMC8820063 | biostudies-literature
Unknown Synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: review and update.
| S-EPMC7236399 | biostudies-literature
Unknown Tofacitinib for the Treatment of Nail Lesions and Palmoplantar Pustulosis in Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis Syndrome.
| S-EPMC7527944 | biostudies-literature
Unknown Pulmonary high-resolution computed tomography findings in patients with synovitis, acne, pustulosis, hyperostosis and osteitis syndrome.
| S-EPMC6281176 | biostudies-literature
Unknown Bone scintigraphy and SPECT/CT imaging characteristics in patients with synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome
| S-EPMC12290804 | biostudies-literature
Unknown Case Report: Successful Treatment of Acute Generalized Exanthematous Pustulosis With Secukinumab.
| S-EPMC8725728 | biostudies-literature
Unknown Case Report: Acute generalized exanthematous pustulosis with psoriasis successfully treated with Secukinumab.
| S-EPMC12672486 | biostudies-literature
Unknown Successful secukinumab therapy in plaque psoriasis is associated with altered gut microbiota and related functional changes.
| S-EPMC10445136 | biostudies-literature
Other Successful secukinumab therapy in plaque psoriasis is associated with altered gut microbiota and related function change
2023-08-07 | GSE239722 | GEO
Other Successful secukinumab therapy in plaque psoriasis is associated with altered gut microbiota and related function change I
2023-08-07 | GSE239719 | GEO